# A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of Cenerimod

> **NCT04819464** · PHASE1 · COMPLETED · sponsor: **Viatris Innovation GmbH** · enrollment: 24 (actual)

## Conditions studied

- Healthy
- Hepatic Impairment

## Interventions

- **DRUG:** Cenerimod

## Key facts

- **NCT ID:** NCT04819464
- **Lead sponsor:** Viatris Innovation GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-25
- **Primary completion:** 2024-08-18
- **Final completion:** 2024-08-18
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04819464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04819464, "A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of Cenerimod". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04819464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*